The tariff classification of Celexa® in dosage form, from Ireland
Reasoning
The tariff classification of Celexa® in dosage form, from Ireland
Cite this ruling
CBP Ruling N208416 (3004909135): The tariff classification of Celexa® in dosage form, from Ireland
Paste this into a product's override reason when citing this ruling as justification for a classification.
Other rulings for HS6 300490
The tariff classification of liquid-filled glass vials ("cartridges") containing the investigational drug Exenatide (CAS-141732-76-5) as the active ingredient, and the tariff classification of a disposable pen injector fitted with a non-removable, liquid-filled glass vial ("cartridge") containing the investigational new drug Exenatide as the active ingredient, both from the United Kingdom
The tariff classification of MLN1021, imported in bulk and measured-dose forms, for use in Phase 1 clinical trials, from the United Kingdom and Canada
The tariff classification of FLUOROPLEX® (fluorouracil) 1% Topical Cream and FLUOROPLEX® (fluorouracil) 1% Topical Solution, supplied put up in 30 g tubes and 30 ml plastic bottles with droppers, respectively, from Canada
The tariff classification of Triple antibiotic ointment (Item No. 0050), Antibiotic plus pain cream (Item No. 0051), Diaper Rash Ointment (Item No. 0052), Hydrocortisone 1% cream (Item No. 0055) and Tolnaftate Antifungal cream (Item No. 0058) over-the-counter medicaments, from Korea
The tariff classification of Triple antibiotic ointment (Item No. 0050), Antibiotic plus pain cream (Item No. 0051), Diaper Rash Ointment (Item No. 0052), Hydrocortisone 1% cream (Item No. 0055) and Tolnaftate Antifungal cream (Item No. 0058) over-the-counter medicaments, from Korea